We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Trevena Inc | NASDAQ:TRVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.006 | -1.41% | 0.42 | 0.4001 | 0.439 | 0.4398 | 0.42 | 0.43 | 78,093 | 23:31:46 |
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
26-1469215
(I.R.S. Employer
Identification Number) |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| | | |
Emerging growth company
☐
|
|
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 11 | | | |
| | | | 14 | | | |
| | | | 15 | | | |
| | | | 17 | | | |
| | | | 17 | | | |
| | | | 17 | | | |
| | | | 18 | | |
Name of Selling Shareholder
|
| |
Number of shares of
Common Stock Owned Prior to Offering |
| |
Maximum Number of
shares of Common Stock to be Sold Pursuant to this Prospectus(1) |
| |
Number of shares of
Common Stock Owned After Offering |
| |||||||||
Armistice Capital, LLC
|
| | | | 13,460,666(2) | | | | | | 11,428,572 | | | | | | 2,032,094 | | |
|
SEC registration fee
|
| | | $ | 1,222.97 | | |
|
Legal fees and expenses
|
| | |
|
(1)
|
| |
|
Accounting fees and expenses
|
| | |
|
(1)
|
| |
|
Transfer agent and trustee fees
|
| | |
|
(1)
|
| |
|
Miscellaneous
|
| | |
|
(1)
|
| |
| Total(2) | | | | $ | (1) | | |
|
Exhibit
No. |
| |
Description
|
|
| 23.1# | | | | |
| 23.2* | | | | |
| 24.1* | | | | |
|
107*
|
| | |
| | | | TREVENA, INC. | | |||
| | | | By: | | |
/s/ Carrie L. Bourdow
Carrie L. Bourdow
President, Chief Executive Officer & Chair of the Board |
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Carrie L. Bourdow
Carrie L. Bourdow
|
| |
President, Chief Executive Officer & Chair of the Board
(Principal Executive Officer) |
| |
January 19, 2024
|
|
|
/s/ Barry Shin
Barry Shin
|
| |
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
| |
January 19, 2024
|
|
|
*
Scott Braunstein, M.D.
|
| |
Lead Independent Director
|
| |
January 19, 2024
|
|
|
*
Mark Corrigan, M.D.
|
| |
Director
|
| |
January 19, 2024
|
|
|
*
Marvin H. Johnson, Jr.
|
| |
Director
|
| |
January 19, 2024
|
|
|
*
Jake R. Nunn
|
| |
Director
|
| |
January 19, 2024
|
|
|
*
Anne M. Phillips, M.D.
|
| |
Director
|
| |
January 19, 2024
|
|
|
*
Barbara Yanni
|
| |
Director
|
| |
January 19, 2024
|
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in Amendment No. 1 to the Registration Statement (Form S-3 No. 333-276458) and related Prospectus of Trevena, Inc. for the registration of shares of its common stock and to the incorporation by reference therein of our report dated March 30, 2023, with respect to the consolidated financial statements of Trevena, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP | |
Philadelphia, Pennsylvania | |
January 19, 2024 |
1 Year Trevena Chart |
1 Month Trevena Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions